SlideShare a Scribd company logo
M. Pharm (Pharmaceutics)
1
Rahul Pal*, Prachi Pandey
Department of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan,
India
Object: To determine the pharmacokinetics and pharmacodynamics of propranolol using WinNonlin®
Software.
References:
01. Certara PhoenixTM
software to Pk/PD management and analysis; https://www.certara
.com/software/pkpd.org
02. Pereira, Laiz Compos et. Al, “Pharmacokinetic/Pharmacodynamic modeling and app. In
antibacterial/fungal pharmacotherapy: A Narrative review”, Antibiotics, Vol. 11, (8); pages no.:
986, 22 July 2022, doi: 10.3390/antibiotics11080986.
Requirements:
• Chemical Moiety: Propranolol
• Software: Phoenix TM
, WinNonlin (subscription) & trial version also used.
Theory:
WinNonlin software are calculates the pk/pd of drug. Propranolol is beta-blocker uses to treat
hypertension, angina & arrhythmias. To calculate its Pk/Pd through WinNonlin software.
The basics steps of software to determine the PK/PD value with WinNonlin software as following:
− Import the data into the WinNonlin software.
− Select the appropriate PK/PD Model
− Fit the model to your data
− Evaluate the model fit
− Calculate the PK/PD parameter
− Generate the reports
01) Import the data into the WinNonlin software: Import the data into the formats, including CVS,
Excel and Text Files.
M. Pharm (Pharmaceutics)
2
02) Selecting the appropriate pk/pd model: The type of pk/pd selected depends on the drug and the data
have. Some common model as follows:
- One compartment Model
- Two compartment Model
- Michaelis-Menten Model
- Emax. Model.
03) Fitting the model to data: WinNonlin uses variety of methods to fit the models to data, including
least squares methods & the maximum likelihood methods.
04) Evaluating the model fit: When fit the model to data, need to evaluate the model fit. This done by
locking at the residual plots and the R-squared values.
05) Calculating the pk/pd parameter: When evaluation had done of model fit, then calculate the pk/pd
parameters. These parameters tell the drug how much absorbed, distribute, metabolized and
eliminated.
06) Generating the reports: WinNonlin can generate a variety of reports in tables, graphs 7 figure. These
reports can use to communicate the result of analysis to others.
EXPERIMENTAL PROCEDURE: The procedure to determine the PK/PD in the software as following:
01. Import the Data: Open WinNonlin, click on the “file” menu & select the “import Data”.
- Select the “table” option & click on the “next button”.
- Select the CSV file that contains your data & click on the
“open” button.
- The data will be imported into the WinNonlin in a table.
Sr. No. Time (hr.) Concentration (mg/mL)
1 0 100
2 1 80
3 2 60
4 3 40
5 4 20
6 5 00
M. Pharm (Pharmaceutics)
3
02. Selecting the appropriate pk/pd model:
One compartment model: ADME of drug are rapidly absorbed & distributed throughout the body.
Two compartment model: ADME of drug are slowly absorbed & distributed throughout the body.
Michaelis Menten Model: The Relation between the drug conc. & response. It describes the rate of
enzymatic reaction.
Emax. Model: Similar to the Michaelis equation, describes the max. response that drug achieved.
Drug Type Appropriate pk/Pd Model Example
Rapidly
absorption/distribution
One compartmental model Aminoglycosides. Warfarin,
propranolol, insulin
Slowly
absorption/distribution
Two compartmental model Digoxin, phenytoin, theophylline
Drug with a clear dose
response relationship
Michaelis Menten equation Warfarin, penicillin,
acetylcholinesterase
Drug with an all-or-
none response
Emax. Aspirin, chlorpheniramine,
epinephrine and nifedipine
03. Fitting the Appropriate Model to data: Here some of the steps as follows:
a) Open WinNonlin software & create the new project: Go to “File”>New>Project. In the project
dialog box, select the modeling project type & click Ok.
b) Import the plasma conc. & time data into WinNonlin Software: Go to “File > Import. In the
import dialog box, select the one compartment model type & click Ok.
c) Create the One compartment model in WinNonlin Software: Go to Model > New Model. In
the new model dialog box., select the one compartment model & click Ok.
d) Fill the model to the using data the Non-Linear Regression tools in WinNonlin Software: Go
to model>, in the fit dialog bx, select the non-linear regression tab. In the model field, select the
one compartment model that, created in step. 3. In the data field, select the plasma conc. data that
you imported in step. 2, click Ok.
e) Evaluate the fit of model to data: Go to “View> Fit result, Fit the results the dialog box will
show you the result of non-linear regression fit. Evaluate the fit of model to data.
M. Pharm (Pharmaceutics)
4
f) Save the model & result.
04. Evaluating the Model Fit:
- Residual plots: Good randomly scattered around the line of zero.
- R- Squared Value: A high R2
Value (closer to 1) indicate- Good Fit.
- Low R2 Value (closer to 0) indicate – Poor fit.
- AIC/BIC: Lowest AIC/BIC mean best fit.
- Visual Inspection: Smooth Curve.
05. Calculating the PK/PD parameters:
- Cl = Dose/AUC
- Vd= AUC/Cmax. – AUC calculate by the go to.
- T1/2 = 1H (2)/Cl – “View> Area Under Curve”. The area under curve dialog box show
AUC for the fitted model.
06. Generating Reports: The reports generate d of Pk reports includes ADME of drug.
- PD reports for relationship between the drug plasma conc. & effect on blood
pressure.
- Safety reports.
Result: The PK/PD of given beta-blocker propranolol drug has been calculated & graph will plot carefully.
Pharmacokinetics parameters Value of parameters of drug
Cl 10L/h
Vd 50L (4L/kg)
Mean Plasma concentration 100mg/mL
Standard deviation 20mg/mL

More Related Content

What's hot

Dissolution profile comparison
Dissolution profile comparisonDissolution profile comparison
Dissolution profile comparison
Mohammad Imran
 
Modified drug delivery systems, Targeted drug delivery and biopharmaceutical ...
Modified drug delivery systems, Targeted drug delivery and biopharmaceutical ...Modified drug delivery systems, Targeted drug delivery and biopharmaceutical ...
Modified drug delivery systems, Targeted drug delivery and biopharmaceutical ...
Durga Bhavani
 
computer aided biopharmaceutical characterization :gastrointestinal absorptio...
computer aided biopharmaceutical characterization :gastrointestinal absorptio...computer aided biopharmaceutical characterization :gastrointestinal absorptio...
computer aided biopharmaceutical characterization :gastrointestinal absorptio...
Affrin Shaik
 
Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)
Himal Barakoti
 
Design and evaluation of bioequivalence
Design and evaluation of bioequivalenceDesign and evaluation of bioequivalence
Design and evaluation of bioequivalence
Chandrika Mourya
 
Computer simulation
Computer simulationComputer simulation
Computer simulation
shashi kiran
 
Computational modelling of drug disposition
Computational modelling of drug disposition Computational modelling of drug disposition
Computational modelling of drug disposition
lalitajoshi9
 
Liposome preparation and evaluation
Liposome preparation and evaluationLiposome preparation and evaluation
Liposome preparation and evaluation
Mohammad Shadab Riyaz
 
Computer simulation in pharmacokinetics and pharmacodynamics
Computer simulation in pharmacokinetics and pharmacodynamicsComputer simulation in pharmacokinetics and pharmacodynamics
Computer simulation in pharmacokinetics and pharmacodynamics
MOHAMMAD ASIM
 
Bioelectronic medicines
Bioelectronic medicinesBioelectronic medicines
Bioelectronic medicines
Durga Bhavani
 
Quality-by-Design in Pharmaceutical Development
Quality-by-Design in Pharmaceutical Development Quality-by-Design in Pharmaceutical Development
Quality-by-Design in Pharmaceutical Development
Raghavendra institute of pharmaceutical education and research .
 
Optimization techniques
Optimization techniquesOptimization techniques
Optimization techniques
pradnyashinde7
 
Drug product performance , in vivo: bioavailability and bioequivalence
Drug product performance , in vivo: bioavailability and bioequivalenceDrug product performance , in vivo: bioavailability and bioequivalence
Drug product performance , in vivo: bioavailability and bioequivalence
DipakKumarGupta3
 
Formulation Building blocks: Building blocks for different product formulatio...
Formulation Building blocks: Building blocks for different product formulatio...Formulation Building blocks: Building blocks for different product formulatio...
Formulation Building blocks: Building blocks for different product formulatio...
PRAJAKTASAWANT33
 
permeability in vivo in vitro in situ.pptx
permeability in vivo in vitro in situ.pptxpermeability in vivo in vitro in situ.pptx
permeability in vivo in vitro in situ.pptx
anumalagundam sreekanth
 
Ich q8 guidelines cadd
Ich q8 guidelines caddIch q8 guidelines cadd
Ich q8 guidelines cadd
ArjunDhawale
 
Clinical significance of bioequivalence study.pptx
Clinical significance of bioequivalence study.pptxClinical significance of bioequivalence study.pptx
Clinical significance of bioequivalence study.pptx
MdSufiyan10
 
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
bhupenkalita7
 
computer simulation in pharmacokinetics and pharmacodynamics
 computer simulation in pharmacokinetics and pharmacodynamics computer simulation in pharmacokinetics and pharmacodynamics
computer simulation in pharmacokinetics and pharmacodynamics
SUJITHA MARY
 
Similarity and difference factors of dissolution
Similarity and difference factors of dissolutionSimilarity and difference factors of dissolution
Similarity and difference factors of dissolution
Jessica Fernandes
 

What's hot (20)

Dissolution profile comparison
Dissolution profile comparisonDissolution profile comparison
Dissolution profile comparison
 
Modified drug delivery systems, Targeted drug delivery and biopharmaceutical ...
Modified drug delivery systems, Targeted drug delivery and biopharmaceutical ...Modified drug delivery systems, Targeted drug delivery and biopharmaceutical ...
Modified drug delivery systems, Targeted drug delivery and biopharmaceutical ...
 
computer aided biopharmaceutical characterization :gastrointestinal absorptio...
computer aided biopharmaceutical characterization :gastrointestinal absorptio...computer aided biopharmaceutical characterization :gastrointestinal absorptio...
computer aided biopharmaceutical characterization :gastrointestinal absorptio...
 
Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)
 
Design and evaluation of bioequivalence
Design and evaluation of bioequivalenceDesign and evaluation of bioequivalence
Design and evaluation of bioequivalence
 
Computer simulation
Computer simulationComputer simulation
Computer simulation
 
Computational modelling of drug disposition
Computational modelling of drug disposition Computational modelling of drug disposition
Computational modelling of drug disposition
 
Liposome preparation and evaluation
Liposome preparation and evaluationLiposome preparation and evaluation
Liposome preparation and evaluation
 
Computer simulation in pharmacokinetics and pharmacodynamics
Computer simulation in pharmacokinetics and pharmacodynamicsComputer simulation in pharmacokinetics and pharmacodynamics
Computer simulation in pharmacokinetics and pharmacodynamics
 
Bioelectronic medicines
Bioelectronic medicinesBioelectronic medicines
Bioelectronic medicines
 
Quality-by-Design in Pharmaceutical Development
Quality-by-Design in Pharmaceutical Development Quality-by-Design in Pharmaceutical Development
Quality-by-Design in Pharmaceutical Development
 
Optimization techniques
Optimization techniquesOptimization techniques
Optimization techniques
 
Drug product performance , in vivo: bioavailability and bioequivalence
Drug product performance , in vivo: bioavailability and bioequivalenceDrug product performance , in vivo: bioavailability and bioequivalence
Drug product performance , in vivo: bioavailability and bioequivalence
 
Formulation Building blocks: Building blocks for different product formulatio...
Formulation Building blocks: Building blocks for different product formulatio...Formulation Building blocks: Building blocks for different product formulatio...
Formulation Building blocks: Building blocks for different product formulatio...
 
permeability in vivo in vitro in situ.pptx
permeability in vivo in vitro in situ.pptxpermeability in vivo in vitro in situ.pptx
permeability in vivo in vitro in situ.pptx
 
Ich q8 guidelines cadd
Ich q8 guidelines caddIch q8 guidelines cadd
Ich q8 guidelines cadd
 
Clinical significance of bioequivalence study.pptx
Clinical significance of bioequivalence study.pptxClinical significance of bioequivalence study.pptx
Clinical significance of bioequivalence study.pptx
 
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
 
computer simulation in pharmacokinetics and pharmacodynamics
 computer simulation in pharmacokinetics and pharmacodynamics computer simulation in pharmacokinetics and pharmacodynamics
computer simulation in pharmacokinetics and pharmacodynamics
 
Similarity and difference factors of dissolution
Similarity and difference factors of dissolutionSimilarity and difference factors of dissolution
Similarity and difference factors of dissolution
 

Similar to Determination of PKPD of Drug Using WinNonlin Software.pdf

Pharsight RAS Expertise
Pharsight RAS ExpertisePharsight RAS Expertise
Pharsight RAS ExpertiseMLJReimer
 
man0 ppt.pptx
man0 ppt.pptxman0 ppt.pptx
man0 ppt.pptx
ManojKumarr75
 
Calculations for Sterile Compounding
Calculations for Sterile Compounding Calculations for Sterile Compounding
Calculations for Sterile Compounding
Kdurant36
 
Disease Prediction And Doctor Appointment system
Disease Prediction And Doctor Appointment  systemDisease Prediction And Doctor Appointment  system
Disease Prediction And Doctor Appointment system
KOYELMAJUMDAR1
 
IRJET - Machine Learning for Diagnosis of Diabetes
IRJET - Machine Learning for Diagnosis of DiabetesIRJET - Machine Learning for Diagnosis of Diabetes
IRJET - Machine Learning for Diagnosis of Diabetes
IRJET Journal
 
ISA FPID Presentation Final 3
ISA FPID Presentation Final 3ISA FPID Presentation Final 3
ISA FPID Presentation Final 3Paul Brodbeck
 
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor ActivityCoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
Kamel Mansouri
 
Meta analysis and spontaneous reporting
Meta analysis and spontaneous reportingMeta analysis and spontaneous reporting
Meta analysis and spontaneous reporting
hamzakhan643
 
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNINGA SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
IRJET Journal
 
EDUC 215Health and Wellness Project OverviewFor this assignmen
EDUC 215Health and Wellness Project OverviewFor this assignmenEDUC 215Health and Wellness Project OverviewFor this assignmen
EDUC 215Health and Wellness Project OverviewFor this assignmen
EvonCanales257
 
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Aldo Shusterman
 
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Aldo Shusterman
 
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATIONA SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
Reshma Fathima .K
 
Presentation1
Presentation1Presentation1
Presentation1
sonalsuryawanshi2
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
DABBETA DIVYA
 
E00 program-level modeling and simulation experiences
E00   program-level modeling and simulation experiencesE00   program-level modeling and simulation experiences
E00 program-level modeling and simulation experiencestherealreverendbayes
 

Similar to Determination of PKPD of Drug Using WinNonlin Software.pdf (20)

Pharsight RAS Expertise
Pharsight RAS ExpertisePharsight RAS Expertise
Pharsight RAS Expertise
 
Session ii g2 lab modeling mmc
Session ii g2 lab modeling mmcSession ii g2 lab modeling mmc
Session ii g2 lab modeling mmc
 
man0 ppt.pptx
man0 ppt.pptxman0 ppt.pptx
man0 ppt.pptx
 
Calculations for Sterile Compounding
Calculations for Sterile Compounding Calculations for Sterile Compounding
Calculations for Sterile Compounding
 
RSI_ReportPDF
RSI_ReportPDFRSI_ReportPDF
RSI_ReportPDF
 
Disease Prediction And Doctor Appointment system
Disease Prediction And Doctor Appointment  systemDisease Prediction And Doctor Appointment  system
Disease Prediction And Doctor Appointment system
 
IRJET - Machine Learning for Diagnosis of Diabetes
IRJET - Machine Learning for Diagnosis of DiabetesIRJET - Machine Learning for Diagnosis of Diabetes
IRJET - Machine Learning for Diagnosis of Diabetes
 
ISA FPID Presentation Final 3
ISA FPID Presentation Final 3ISA FPID Presentation Final 3
ISA FPID Presentation Final 3
 
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor ActivityCoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
 
Meta analysis and spontaneous reporting
Meta analysis and spontaneous reportingMeta analysis and spontaneous reporting
Meta analysis and spontaneous reporting
 
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNINGA SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
 
EDUC 215Health and Wellness Project OverviewFor this assignmen
EDUC 215Health and Wellness Project OverviewFor this assignmenEDUC 215Health and Wellness Project OverviewFor this assignmen
EDUC 215Health and Wellness Project OverviewFor this assignmen
 
CO4_2015_LOW_36-39
CO4_2015_LOW_36-39CO4_2015_LOW_36-39
CO4_2015_LOW_36-39
 
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
 
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
 
resumeliliane
resumelilianeresumeliliane
resumeliliane
 
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATIONA SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
 
Presentation1
Presentation1Presentation1
Presentation1
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
 
E00 program-level modeling and simulation experiences
E00   program-level modeling and simulation experiencesE00   program-level modeling and simulation experiences
E00 program-level modeling and simulation experiences
 

More from RAHUL PAL

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
RAHUL PAL
 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
RAHUL PAL
 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdf
RAHUL PAL
 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
RAHUL PAL
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
RAHUL PAL
 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdf
RAHUL PAL
 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
RAHUL PAL
 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...
RAHUL PAL
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
RAHUL PAL
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
RAHUL PAL
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
RAHUL PAL
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
RAHUL PAL
 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptx
RAHUL PAL
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
RAHUL PAL
 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
RAHUL PAL
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
RAHUL PAL
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
RAHUL PAL
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
RAHUL PAL
 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
RAHUL PAL
 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
RAHUL PAL
 

More from RAHUL PAL (20)

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdf
 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdf
 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptx
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
 

Recently uploaded

"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 

Recently uploaded (20)

"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 

Determination of PKPD of Drug Using WinNonlin Software.pdf

  • 1. M. Pharm (Pharmaceutics) 1 Rahul Pal*, Prachi Pandey Department of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan, India Object: To determine the pharmacokinetics and pharmacodynamics of propranolol using WinNonlin® Software. References: 01. Certara PhoenixTM software to Pk/PD management and analysis; https://www.certara .com/software/pkpd.org 02. Pereira, Laiz Compos et. Al, “Pharmacokinetic/Pharmacodynamic modeling and app. In antibacterial/fungal pharmacotherapy: A Narrative review”, Antibiotics, Vol. 11, (8); pages no.: 986, 22 July 2022, doi: 10.3390/antibiotics11080986. Requirements: • Chemical Moiety: Propranolol • Software: Phoenix TM , WinNonlin (subscription) & trial version also used. Theory: WinNonlin software are calculates the pk/pd of drug. Propranolol is beta-blocker uses to treat hypertension, angina & arrhythmias. To calculate its Pk/Pd through WinNonlin software. The basics steps of software to determine the PK/PD value with WinNonlin software as following: − Import the data into the WinNonlin software. − Select the appropriate PK/PD Model − Fit the model to your data − Evaluate the model fit − Calculate the PK/PD parameter − Generate the reports 01) Import the data into the WinNonlin software: Import the data into the formats, including CVS, Excel and Text Files.
  • 2. M. Pharm (Pharmaceutics) 2 02) Selecting the appropriate pk/pd model: The type of pk/pd selected depends on the drug and the data have. Some common model as follows: - One compartment Model - Two compartment Model - Michaelis-Menten Model - Emax. Model. 03) Fitting the model to data: WinNonlin uses variety of methods to fit the models to data, including least squares methods & the maximum likelihood methods. 04) Evaluating the model fit: When fit the model to data, need to evaluate the model fit. This done by locking at the residual plots and the R-squared values. 05) Calculating the pk/pd parameter: When evaluation had done of model fit, then calculate the pk/pd parameters. These parameters tell the drug how much absorbed, distribute, metabolized and eliminated. 06) Generating the reports: WinNonlin can generate a variety of reports in tables, graphs 7 figure. These reports can use to communicate the result of analysis to others. EXPERIMENTAL PROCEDURE: The procedure to determine the PK/PD in the software as following: 01. Import the Data: Open WinNonlin, click on the “file” menu & select the “import Data”. - Select the “table” option & click on the “next button”. - Select the CSV file that contains your data & click on the “open” button. - The data will be imported into the WinNonlin in a table. Sr. No. Time (hr.) Concentration (mg/mL) 1 0 100 2 1 80 3 2 60 4 3 40 5 4 20 6 5 00
  • 3. M. Pharm (Pharmaceutics) 3 02. Selecting the appropriate pk/pd model: One compartment model: ADME of drug are rapidly absorbed & distributed throughout the body. Two compartment model: ADME of drug are slowly absorbed & distributed throughout the body. Michaelis Menten Model: The Relation between the drug conc. & response. It describes the rate of enzymatic reaction. Emax. Model: Similar to the Michaelis equation, describes the max. response that drug achieved. Drug Type Appropriate pk/Pd Model Example Rapidly absorption/distribution One compartmental model Aminoglycosides. Warfarin, propranolol, insulin Slowly absorption/distribution Two compartmental model Digoxin, phenytoin, theophylline Drug with a clear dose response relationship Michaelis Menten equation Warfarin, penicillin, acetylcholinesterase Drug with an all-or- none response Emax. Aspirin, chlorpheniramine, epinephrine and nifedipine 03. Fitting the Appropriate Model to data: Here some of the steps as follows: a) Open WinNonlin software & create the new project: Go to “File”>New>Project. In the project dialog box, select the modeling project type & click Ok. b) Import the plasma conc. & time data into WinNonlin Software: Go to “File > Import. In the import dialog box, select the one compartment model type & click Ok. c) Create the One compartment model in WinNonlin Software: Go to Model > New Model. In the new model dialog box., select the one compartment model & click Ok. d) Fill the model to the using data the Non-Linear Regression tools in WinNonlin Software: Go to model>, in the fit dialog bx, select the non-linear regression tab. In the model field, select the one compartment model that, created in step. 3. In the data field, select the plasma conc. data that you imported in step. 2, click Ok. e) Evaluate the fit of model to data: Go to “View> Fit result, Fit the results the dialog box will show you the result of non-linear regression fit. Evaluate the fit of model to data.
  • 4. M. Pharm (Pharmaceutics) 4 f) Save the model & result. 04. Evaluating the Model Fit: - Residual plots: Good randomly scattered around the line of zero. - R- Squared Value: A high R2 Value (closer to 1) indicate- Good Fit. - Low R2 Value (closer to 0) indicate – Poor fit. - AIC/BIC: Lowest AIC/BIC mean best fit. - Visual Inspection: Smooth Curve. 05. Calculating the PK/PD parameters: - Cl = Dose/AUC - Vd= AUC/Cmax. – AUC calculate by the go to. - T1/2 = 1H (2)/Cl – “View> Area Under Curve”. The area under curve dialog box show AUC for the fitted model. 06. Generating Reports: The reports generate d of Pk reports includes ADME of drug. - PD reports for relationship between the drug plasma conc. & effect on blood pressure. - Safety reports. Result: The PK/PD of given beta-blocker propranolol drug has been calculated & graph will plot carefully. Pharmacokinetics parameters Value of parameters of drug Cl 10L/h Vd 50L (4L/kg) Mean Plasma concentration 100mg/mL Standard deviation 20mg/mL